𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical implications of minimal disease in the bone marrow and peripheral blood in neuroblastoma

✍ Scribed by Kumiko Shono; Tatsurou Tajiri; Yoshimitsu Fujii; Sachiyo Suita

Book ID
117826625
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
291 KB
Volume
35
Category
Article
ISSN
0022-3468

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Flow cytometric analysis of peripheral b
Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma
✍ Yoshihiro Komada; Xao-Li Zhang; Yan-Wen Zhou; Hiroto Inaba; Takao Deguchi; Eiich πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 211 KB πŸ‘ 2 views

## Background: Several sensitive surveillance tests reportedly have been used to detect occult neuroblastoma (nb) cells in peripheral blood (pb) and bone marrow (bm). they may be useful in monitoring minimal residual tumor cells. the authors report the feasibility and clinical usefulness of a sensi

Megakaryocyte progenitors in the bone ma
Megakaryocyte progenitors in the bone marrow and peripheral blood of patients with myeloproliferative diseases
✍ Alberto Grossi; Alessandro M. Vannucchi; Daniela Rafanelli; Letizia Vannucchi; P πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 397 KB πŸ‘ 2 views

We studied the behavior in culture of megakaryocyte progenitor cells (CFU-Mk) from peripheral blood (PB) and bone marrow (BM) cells in eight patients with myeloproliferative diseases (MPD). In seven patients we observed megakaryocyte (Mk) colony formation from PB cells, which were generated in the a

Outcome prediction by molecular detectio
Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma
✍ Horibe, Keizo ;Fukuda, Minoru ;Miyajima, Yuji ;Matsumoto, Kimikazu ;Kondo, Masar πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 88 KB πŸ‘ 2 views

Background. We have determined whether sequential molecular detection of minimal residual disease (MRD) in bone marrow (BM) could predict the outcome of patients with advanced neuroblastoma (NB). Procedure. Bone marrow samples from 19 patients over 12 months of age with stage 4 neuroblastoma were se